Loading clinical trials...
Loading clinical trials...
Multicenter, Open Label Trial to Investigate the Efficacy and Safety of a Single Oral Dose of 1.0 mg/kg Macimorelin Acetate as Growth Hormone Stimulation Test (GHST) in Pediatric Patients With Suspected Growth Hormone Deficiency (GHD)
Conditions
Interventions
Macimorelin
Arginine
+1 more
Locations
45
United States
Angel Wing Clinic For Children With Diabetes
Tucson, Arizona, United States
Pediatric Endocrine Associates, p.c.
Greenwood Village, Colorado, United States
John Hopkins All Children's Hospital
St. Petersburg, Florida, United States
Emory Healthcare-Children's Center
Atlanta, Georgia, United States
St. Luke's Children's Endocrinology
Boise, Idaho, United States
University of Minnesota, Masonic Children's Hospital
Minneapolis, Minnesota, United States
Start Date
November 16, 2021
Primary Completion Date
June 13, 2024
Completion Date
June 13, 2024
Last Updated
August 12, 2024
NCT07333521
NCT00227253
NCT01604395
NCT06109935
NCT05796440
NCT05230550
Lead Sponsor
AEterna Zentaris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions